Skip to main content
Premium Trial:

Request an Annual Quote

Celera Diagnostics, Abbott Labs Ink Broad Molecular-Diagnostics Collaboration

Click here to view an updated version of this article.

NEW YORK, June 24 - Celera Diagnostics and Abbott Labs will partner to develop and market a "broad range" of in vitro molecular diagnostics to detect and monitor a variety of diseases, the companies said today.

Roughly 250 scientists and engineers from both firms will hunt markers to infectious diseases, cancer, central nervous system disorders, and cardiovascular and autoimmune diseases, the companies said.

Specifically, Celera Diagnostics will focus on discovering and validating genetic markers and developing assays while Abbott concentrates on product development, sales, and marketing, the partners said. The companies stressed they will not try to develop or commercialize proteins, immunoassays, or products for either the research or pharmaceutical markets.

Under the terms of the agreement, which reflects Celera Diagnostics' only alliance since it was formed slightly more than one year ago, the companies will share expenses and profits tied to researching, developing, manufacturing, and commercializing any products that may arise. Abbott also will distribute worldwide "most" products.

The partners agreed to share each other's technologies and patents; Abbott researchers will have access to Applied Biosystems' instruments and Celera Genomics' gene data and analytical tools, for example.  


Celera said it plans to host a conference call tomorrow at 10:00 a.m. Eastern time. Click here for more information.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.